Cargando…
EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300370/ http://dx.doi.org/10.1016/j.annonc.2022.05.376 |
| _version_ | 1784751198058840064 |
|---|---|
| author | Yamamoto, Noboru |
| author_facet | Yamamoto, Noboru |
| author_sort | Yamamoto, Noboru |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9300370 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | European Society for Medical Oncology. Published by Elsevier Ltd. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-93003702022-07-21 EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design Yamamoto, Noboru Ann Oncol Article European Society for Medical Oncology. Published by Elsevier Ltd. 2022-07 2022-07-21 /pmc/articles/PMC9300370/ http://dx.doi.org/10.1016/j.annonc.2022.05.376 Text en Copyright © 2022 European Society for Medical Oncology. Published by Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Yamamoto, Noboru EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title | EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title_full | EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title_fullStr | EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title_full_unstemmed | EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title_short | EJS-4 The impact of COVID-19 pandemic on the new drug development and exploration of new trial design |
| title_sort | ejs-4 the impact of covid-19 pandemic on the new drug development and exploration of new trial design |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9300370/ http://dx.doi.org/10.1016/j.annonc.2022.05.376 |
| work_keys_str_mv | AT yamamotonoboru ejs4theimpactofcovid19pandemiconthenewdrugdevelopmentandexplorationofnewtrialdesign |